Page last updated: 2024-10-22

albuterol and Hypertension, Portal

albuterol has been researched along with Hypertension, Portal in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martínez-Cuesta, MA1
Moreno, L1
Piqué, JM1
Bosch, J1
Rodrigo, J1
Esplugues, JV1

Other Studies

1 other study available for albuterol and Hypertension, Portal

ArticleYear
Nitric oxide-mediated beta 2-adrenoceptor relaxation is impaired in mesenteric veins from portal-hypertensive rats.
    Gastroenterology, 1996, Volume: 111, Issue:3

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Electric Stimulation; Hypertension, Portal; Immunohist

1996